• Explore /
  • Poster
  • / Chemoradiation with FOLFOX plus cetuximab in locally advanced cardia or esophageal cancer: Final results of a GERCOR phase II trial (ERaFOX).

Chemoradiation with FOLFOX plus cetuximab in locally advanced cardia or esophageal cancer: Final results of a GERCOR phase II trial (ERaFOX).

Abstract Poster

Authors

null

L. Dahan

APHM La Timone, Marseille, France

L. Dahan , B. Chibaudel , F. Di Fiore , P. Artru , L. Mineur , M. Galais , O. Dupuis , V. Blondin , S. Abdiche , M. Attia , A. De Gramont , G. Lledo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal, Gastric, or Small Bowel

Clinical Trial Registration Number

NCT00578201

Citation

J Clin Oncol 29: 2011 (suppl; abstr 4072)

Abstract #

4072

Poster Bd #

31F

Abstract Disclosures

Similar Posters

First Author: Yongkang Xu

First Author: Karyn A. Goodman

Poster

2014 Gastrointestinal Cancers Symposium

Combining cetuximab with FOLFOX regimen as the first-line therapy of <i>KRAS</i> wild-type advanced gastric cancer.

Combining cetuximab with FOLFOX regimen as the first-line therapy of KRAS wild-type advanced gastric cancer.

First Author: Yung-Sung Yeh

First Author: Manabu Muto